LL-37 10MG FOR SALE

Description

LL-37 10mg is a high-purity research peptide derived from the human cathelicidin antimicrobial peptide family, widely studied in the fields of innate immunity, antimicrobial defense mechanisms, inflammation regulation, and tissue repair biology. As the only known human cathelicidin peptide, LL-37 plays a central role in first-line immune defense and has become a major focus of biomedical research exploring host-defense peptides and immune system signaling pathways.

LL-37 is primarily investigated for its involvement in innate immune responses. It is naturally produced by various cells, including neutrophils and epithelial tissues, where it contributes to the body’s ability to respond to microbial challenges. Research has extensively examined how LL-37 interacts with bacterial membranes, immune receptors, and inflammatory signaling pathways, making it a key compound in studies of host defense mechanisms.

One of the primary areas of interest for LL-37 10mg is its antimicrobial research profile. Scientific studies have explored its ability to disrupt microbial cell membranes and influence pathogen viability in controlled experimental settings. Because of its broad-spectrum activity in innate immunity models, LL-37 is frequently included in laboratory investigations focused on antimicrobial peptides and alternative immune defense strategies.

LL-37 is also widely studied in inflammation and immune modulation research. Beyond its antimicrobial properties, it plays a role in regulating cytokine activity, chemotaxis, and immune cell signaling. Researchers continue to investigate how LL-37 may contribute to both the activation and resolution phases of inflammatory responses, depending on the biological context. This dual functionality makes it an important subject in immunology research.

Another significant area of study involves tissue repair and regenerative biology. LL-37 has been examined for its potential involvement in wound healing processes, including epithelial regeneration, angiogenesis, and cellular migration. These properties have made it relevant in research focused on skin repair, mucosal healing, and recovery mechanisms following injury in experimental models.

LL-37 is also studied in the context of epithelial barrier function. Epithelial tissues serve as a critical interface between the body and external environment, and LL-37 is believed to play a role in maintaining barrier integrity and immune surveillance. Researchers continue to evaluate how this peptide contributes to protecting epithelial surfaces while coordinating immune responses to environmental stressors.

In addition to immune and tissue-related functions, LL-37 is included in broader studies of systemic inflammation and cellular stress responses. Its involvement in multiple signaling pathways has made it a valuable tool for understanding how innate immunity interfaces with regenerative and inflammatory biology at the molecular level.

The 10mg formulation of LL-37 is designed for precision research applications, offering a consistent and reliable concentration suitable for laboratory environments. High purity and strict manufacturing standards ensure stability, reproducibility, and accuracy across experimental conditions. Each vial contains 10mg of LL-37, making it suitable for a wide range of immunology and peptide research protocols.

As interest in host-defense peptides and innate immunity continues to grow, LL-37 remains one of the most extensively studied antimicrobial peptides in modern biomedical science. Its dual role in antimicrobial defense and immune regulation has made it a cornerstone compound in immunology and regenerative research.

For researchers seeking a high-quality peptide for advanced studies in innate immunity, antimicrobial defense, and inflammation regulation, LL-37 10mg represents a reliable and scientifically significant option. Its strong biological relevance and extensive research background continue to make it a leading compound in modern immune and peptide science.